Market revenue in 2023 | USD 119.6 million |
Market revenue in 2030 | USD 351.1 million |
Growth rate | 16.6% (CAGR from 2023 to 2030) |
Largest segment | Ctms |
Fastest growing segment | ECOA |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | ECOA, EDC & CDMS, Clinical Analytics Platforms, Clinical Data Integration Platforms, Safety solutions, CTMS, RTSM, ETMF, EConsent |
Key market players worldwide | DATATRAK International Inc, Oracle Corp, PAREXEL, Dassault Systemes SE, Signant Health, Clario, eClinicalWorks, International Business Machines Corp, IQVIA Holdings Inc, Veeva Systems Inc Class A, Anju Software, MaxisIT Inc., Castor |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to eclinical solutions market will help companies and investors design strategic landscapes.
Ctms was the largest segment with a revenue share of 21.57% in 2023. Horizon Databook has segmented the Mexico eclinical solutions market based on ecoa, edc & cdms, clinical analytics platforms, clinical data integration platforms, safety solutions, ctms, rtsm, etmf, econsent covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico is expected to witness lucrative growth in coming years. According to ClinicalTrials.gov the number of clinical trials conducted in Mexico has increased. The studies conducted in the country were mostly phase III clinical trials that intended to test the large-scale safety and efficacy of new molecules in drug development.
Mexico has improved its regulatory environment due to local presence of international CROs such as Calyx. Mexico's large ageing population base, high number of patients, improved regulatory environment, and low cost in clinical trials has made it an attractive place for clinical trial outsourcing. Mexico’s Ministry of health, COFEPRIS, declared that Mexico is the most viable Central & South American country in clinical protocols for new drug development.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico eclinical solutions market , including forecasts for subscribers. This country databook contains high-level insights into Mexico eclinical solutions market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account